The current price of ABCL is $11.13 — it has decreased by 9.36% since the previous close. Data as of Nov 5, 2026.
ABCL is down 12.02% over the past week, down 19.23% over the past month and up 137.31% over the past year. The price is above its 200-day moving average of $6.97.
AbCellera Biologics Inc. has a market capitalization of $3.61B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
Companies most comparable to AbCellera Biologics Inc. include Generate Biomedicines, Inc., Absci Corporation and Ginkgo Bioworks Holdings, Inc.
In the latest trading session ABCL moved between $10.76 and $11.88, a range of 10.06% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of AbCellera Biologics Inc. shows a sell rating today. Technical ratings are indicators, not investment advice.
Over the past 52 weeks ABCL has traded between $2.75 and $15.02. The current price is 25.90% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.